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level. The development of the performance measures over time may be attributed 
to changes in organization and management of the system. Methods: As routine 
data the ATHIS 2006/2007 (a standardized health interview survey), the cause of 
death registry 2006 and 2007, the hospital discharge datasets from the Austrian 
DRG system 2006/2007 (KDok/DLD) and diagnoses for the outpatient sector derived 
from pharmaceutical claims data 2006/2007 (ATC→ICD) - are used to describe the 
burden of disease regarding Ischemic Heart Disease (ICD9 410–414) with differ-
ent regional granularity. Methods and results are compared with epidemiological 
data extracted from a literature search on this topic. To explore the similarity 
of the results of these different methods of measurement a systematic review of 
regional correlation is being elaborated. Correlations pointing to a high analogy of 
the findings in spite of the differences in dimensions measured on the one hand and 
contra intuitive correlations on the other hand were further explored. Results: The 
review of regional correlation indicates promising close links between the burden 
of disease derived from ATC→ICD, ATHIS and cause of death registry data. Hospital 
discharge data, however, show some contra-intuitive relations towards the other 
data sets. ConClusions: The use of routine data yields promising opportunities 
for monitoring the Austrian health care system in a timely and comprehensible 
way. It enables different aggregation levels regarding regions and periods and leads 
the way to further research addressing underlying causes for the observed regional 
variation. The methodology can be transferred to other areas of diseases.
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objeCtives: Abdominal Aorta Aneurysms (AAAs) refers to distension of the abdominal 
aorta. It is a common disease among 65+ year old people with increasing importance due 
to overageing of the population. Currently, AAAs in Austria are only incidentally detected 
and due to its asymptomatic course often overlooked therefore the impact of an organ-
ized screening program in Austria was evaluated. Methods: An agent based simulation 
model for Austria’s population was developed. Each agent represents a person which 
has an individual development of its aorta depending on age, sex, and smoking habits. 
Identification of risk factors and parameterization of the model was performed in the 
IFEDH project (FFG grant number 827347). The observed persons are 65 years old at 
simulation start and the observed time horizon is 20 years. The chosen screening strat-
egy which is compared to current practice corresponds to the EUnetHTA scheme with 
an assumed 40% participation. Results: Events like ruptures, deaths or treatment are 
recorded and accumulated over the whole simulation time. Additionally, because many 
figures of the model depend on probabilities, the point in time when patients benefit 
from the intervention with 95% probability is calculated. Ruptures are reduced from 786 
to 531, death cases from 571 to 433 whereas the costs per life year gained are about 7500 
€ . Significant differences can be observed after about four years. Although incidence 
is much higher among men, it is remarkable that screening is more cost-effective for 
women due to higher risk of rupture and life expectancy. ConClusions: The agent 
based simulation model allows detailed analysis of groups with specific properties, e.g. 
smokers, other age groups and different screening strategies. It also allows decision 
makers to estimate when the impact of the intervention, in this case organized screen-
ing, can be observed or measured within the real population.
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objeCtives: To estimate the potential added value of an ultrasound-fluoroscopy 
fusion technology and to support product development and marketing positioning 
of the technology in interventional cardiology, using a combination of research 
methods. Methods: Stakeholder analysis was carried out to determine the profes-
sionals involved in the adoption process. Literature search indicated which proce-
dures could benefit most from the imaging technology. Subsequently, the current 
workflow and associated resource use of those procedures was compared with the 
expected workflow after potential technology adoption. Decision criteria to adopt 
the new imaging technology were evaluated with the analytical hierarchy process 
(AHP). Finally, a value based pricing approach was used to estimate the value of the 
technology to specific types of hospitals. Results: Intervention cardiologists were 
identified as key stakeholders in the adoption of technology. The AHP showed that 
reduction in complication rates is the most important criterion for adopting a new 
imaging technology, whereas the purchase price seemed less important. Various 
procedures could benefit from the new technology, as this may shorten procedural 
times and facilitate communication between intervention cardiologists and imag-
ing professionals. Value based pricing analysis showed that cost savings could be 
expected as a result of reduced procedure times, especially in centers of expertise 
with medium to high procedure volumes. ConClusions: The ultrasound-fluoros-
copy fusion technology can provide added value in specific cardiac interventions, 
especially in hospitals with medium to high procedure volumes. Early assessment 
of potential added value and adoption criteria timely and effectively supported the 
product development phase. It informed various decision makers on the factors 
influencing the expected value of and uncertainties surrounding a future adoption 
of the technology.
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risk-adjustment. Furthermore, we have a ZIP-code for each patient and the exact 
address for every hospital. Addresses of hospitals and the centroids of all German ZIP 
codes were geo-coded. For the empirical analysis, we use multiple logistic regression 
analysis. We supplement our analysis by showing changes in access to hospitals if a 
minimum volume standard is introduced. Results: Patients with hip fracture who 
are treated in hospitals with less than 58 cases per year have an average probability of 
death of 5.1 % compared to an average mortality of 3.1 % for patients who are treated 
in hospitals with more than 151 cases. For patients with AAA the case volume effect 
is lower. However, compared to patients treated in hospitals with less than 15 cases 
per year, the average probability of death for patients treated in hospitals with more 
than 68 cases is 1.0 percentage points less. We show that minimum volume standards 
seem possible without compromising overall access. ConClusions: The estima-
tion results suggest that around 380 deaths could have been presumably avoided, 
if around 20,000 patients in the smallest hospitals would have been treated in the 
largest hospitals instead. Furthermore, we show that minimum volume standards 
do not compromise overall access measured in travel times. However, to ensure an 
adequate access in all areas, a few “sole providers” in some regions seem necessary.
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objeCtives: Drug prescriptions recorded in health care administrative databases 
(HADs) can be an indicator of moderate health outcomes (undetectable through hos-
pitalization or death registries) correlated to particulate matter (PM) exposure. This 
study is aimed at assessing the short-term effect of PM10 exposure on the risk of car-
diorespiratory drug prescription in Lombardy, a region in northern Italy. Methods: 
For each resident in seven cities of Lombardy, we identified all prescriptions of 
selected respiratory, cardiovascular and antidiabetic treatments recorded during 
2005-2006 in data warehouse DENALI, which gathers HADs of Lombardy health 
system. The Regional Environmental Protection Agency of Lombardy provided time-
series of daily mean PM10 concentration. We applied a time-stratified case-crossover 
design matched by day of week and fitted separate Cox proportional hazard models 
for each respiratory and cardiovascular treatment. Confounding was accounted for 
using a method, which we developed, based on the time-series of prescription of 
antidiabetics. Analyses were replicated for delayed effects of PM up to 6 days and 
for warm and cold season. Results: The study area counted 470,300 residents, 
requiring 655,805 prescriptions. Mean PM10 concentration was 48µg/m
3 (SD 32µg/
m3). Overall, we estimated that rises in PM10 concentration were associated with 
an immediate increment in the risk of prescription of inhalant adrenergics (0.32% 
for increments of 10µg/m3 in PM10 concentration; 95%CI:0.00,0.65), antiarrhythmics 
(0.52%; 95%CI:0.16,0.87) and nitrates (0.51%; 95%CI:0.27,0.76). Increased PM10 expo-
sure was also positively associated with the prescription of inhalant glucocorticoids 
during the warm season and of inhalant adrenergics, antiarrhythmics and nitrates 
during the cold season. ConClusions: The significant association that we detected 
between PM concentration and drug prescriptions suggests that PM exposure may 
impact public health not only through severe but also through moderate adverse 
events. Further investigation is needed and given the usual difficulty retrieving 
information on moderate outcomes, HADs represent a valuable data source.
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objeCtives: To estimate the impact of hypercholesterolemia (HYP) on population 
health in Portugal. Methods: We estimate the Disability Adjusted Life-Years (DALY) 
attributable to HYP in 2010. The DALY include both years lost to premature death and 
years lost to disability. HYP is a risk factor for Acute Myocardial Infarction (ICD 9 410), 
other Coronary Heart Diseases (ICD 9 411-414) and for Ischemic Stroke (ICD 9 433-434). 
In order to estimate the attributable fractions to HYP of the diseases considered a 
microsimulation approach was used by using Framingham equations on data from 
individual observations in the VALSIM database. A total cholesterol equal to the mean 
for observations above 200 mg/dL was imputed to all individuals under statin treat-
ment. In a counterfactual scenario HYP was eliminated (reducing total cholesterol to 
200 mg/dL and increasing HDL to 40 mg/dL in all cases with HYP). The resulting pro-
portional change in the probability of events was taken as the HYP attributable fraction 
of the diseases studied. Results: In Portugal the prevalence of HYP in 2010 was esti-
mated at 55,5% of the population over 18 (56,7% male and 54,5% female). In 2010 there 
were 1689 deaths attributable to HYP. This number can be broken down by gender (640 
males and 1050 females) or by disease (481 from Acute Myocardial Infarction, 235 from 
other ischemic heart disease and 974 from ischemic stroke). DALY for premature death 
were estimated at 7263, and DALY for disability at 8239. Of the total 15502 DALY attrib-
utable to HYP 6132 were for ischemic stroke and 9369 for coronary disease. Gender 
decomposition of this total was 8012 for males and 7489 for females. ConClusions: 
The analysis suggests that HYP is an important cause of disease burden in Portugal 
and that it should remain a major target for health policy interventions.
PCV164
utilizAtion of routine dAtA for regionAlized ePidemiology in 
AustriA - the exAmPle of isChemiC heArt diseAse (iCd9 410-414)
Endel G.1, Fülöp G.2
1Main Association of Austrian Social Security Institutions, Vienna, Austria, 2Gesundheit Österreich 
GmbH - GÖG, Vienna, Austria
objeCtives: Monitoring the performance of the health care system requires 
timely and robust information highlighting the burden of disease on a regional 
